N04 RAD-TOX
NDC 63479-1404, ALOE SOCOTRINA, BONE MARROW SUIS, BOS TAURUS PLACENTA, BOS TAURUS SKIN, DNA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, FERRUM METALLICUM, FUCUS VESICULOSUS, IODIUM, KALI PHOSPHORICUM, PHOSPHORUS, RIBES NIGRUM FLOWER BUD, SOY LECITHIN, VITAMIN A ACETATE, VITAMIN E ACETATE, solution/ drops, from Apex Energetics Inc..
- Product NDC
- 63479-1404
- Status
- Listed
- Labeler
- Apex Energetics Inc.
- Dosage form
- SOLUTION/ DROPS
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63479-1404 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HERRING SPERM DNA12 [hp_X]/mL
- BOS TAURUS PLACENTA7 [hp_C]/mL
- IRON30 [hp_X]/mL
- IODINE30 [hp_X]/mL
- DIBASIC POTASSIUM PHOSPHATE30 [hp_X]/mL
- PHOSPHORUS30 [hp_X]/mL
- RIBES NIGRUM FLOWER BUD8 [hp_X]/mL
- LECITHIN, SOYBEAN9 [hp_X]/mL
- ALOE12 [hp_X]/mL
- SUS SCROFA BONE MARROW7 [hp_C]/mL
- ECHINACEA ANGUSTIFOLIA6 [hp_X]/mL
- ECHINACEA PURPUREA6 [hp_X]/mL
- BOS TAURUS SKIN7 [hp_C]/mL
- FUCUS VESICULOSUS9 [hp_X]/mL
- VITAMIN A ACETATE9 [hp_X]/mL
- .ALPHA.-TOCOPHEROL ACETATE9 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Cells, Epidermal [EXT]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Animal Skin Allergenic Extract [EPC]; Vitamin A [CS]; Vitamin A [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63479-1404-1 | 63479140401 | 30 mL in 1 BOTTLE, GLASS (63479-1404-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63479-1404 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63479-1404 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63479-1404. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.